a16z Podcast: The Economics of Expensive Medicines
The a16z Show30 Mai 2019

a16z Podcast: The Economics of Expensive Medicines

with Andrew Lo (@AndrewWLo) and Jorge Conde (@JorgeCondeBio)

The advent of new gene and cell therapies are beginning to approach that holy grail of medicine—that of a possible cure. But they are also more expensive than any medicines ever sold before. In this episode, MIT economist Andrew Lo and a16z General Partner on the Bio Fund Jorge Conde discuss how exactly we place an economic value on a cure; the questions we still need to figure out, like who should pay for what and how; and how we need to start thinking about handling the coming influx of highly priced medicines like these into our healthcare system.

If we think about these payments as a kind of 'mortgage for a cure,' what happens when your gene therapy mortgage defaults? How would payment plans like these move between insurance plans? Lo and Conde also discuss the broader context in our healthcare system, the economics and risk of drug discovery and development overall – and finally, how our markets might just function more like biological systems than anything else.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episoder(1000)

AI Startups vs. Big Chatbots — With Olivia Moore

AI Startups vs. Big Chatbots — With Olivia Moore

In this episode, originally aired on Big Technology Podcast, Olivia Moore discusses whether AI startups can compete with the big chatbots, why American sentiment toward AI is so negative, and what she...

16 Mar 56min

Marc Andreessen on the Mindset of Great Founders — with David Senra

Marc Andreessen on the Mindset of Great Founders — with David Senra

Marc Andreessen joins David Senra for a conversation about entrepreneurship, history, and what drives some of the world’s most ambitious builders. In this conversation with David, Marc reflects on pat...

15 Mar 1h 49min

Emil Michael: Iran, Anthropic and the Future of AI at the Pentagon

Emil Michael: Iran, Anthropic and the Future of AI at the Pentagon

This conversation with Emil Michael, undersecretary of defense for research and engineering and acting director of the Defense Innovation Unit, was recorded at the a16z American Dynamism Summit in Was...

13 Mar 27min

Palantir CEO Alex Karp on the Zero-Sum AI Race

Palantir CEO Alex Karp on the Zero-Sum AI Race

This conversation with Alex Karp, cofounder and CEO of Palantir, was recorded at the a16z American Dynamism Summit in Washington, D.C. Karp discusses the role of technology in modern warfare, Silicon ...

12 Mar 32min

What It Takes to Clear a Million Crimes a Year with Flock Safety's CEO

What It Takes to Clear a Million Crimes a Year with Flock Safety's CEO

In this episode, previously aired on Cheeky Pint, Garrett Langley describes how a stolen gun in his Atlanta neighborhood led him to build Flock Safety, now deployed in more than 6,000 cities and invol...

11 Mar 1h 46min

The Top 100 Gen AI Consumer Apps

The Top 100 Gen AI Consumer Apps

Anish Acharya speaks with Olivia Moore about the latest edition of the a16z Top 100 AI Apps report. They cover why ChatGPT is still 30 times bigger than Claude on web, how the three major platforms ar...

10 Mar 40min

Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

Daisy Wolf speaks with Dr. Andrew Huberman, professor of neurobiology and ophthalmology at Stanford University and host of the Huberman Lab podcast. They discuss how the pandemic sparked a consumer he...

9 Mar 51min

Atlassian CEO on the SaaS Apocalypse, AI Agents & What Comes Next

Atlassian CEO on the SaaS Apocalypse, AI Agents & What Comes Next

Alex Rampell and Erik Torenberg speak with Mike Cannon-Brookes, cofounder and CEO of Atlassian, about how to make sense of the SaaS selloff, why not all software companies face the same AI-driven risk...

6 Mar 55min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
livet-pa-veien-med-jan-erik-larssen
finansredaksjonen
pengepodden-2
pengesnakk
utbytte
tid-er-penger-en-podcast-med-peter-warren
morgenkaffen-med-finansavisen
rss-sunn-okonomi
stormkast-med-valebrokk-stordalen
lederpodden
rss-markedspuls-2
liberal-halvtime
rss-politisk-preik
lederskap-nhhs-podkast-om-ledelse